Skip to content

A retrospective study comparing intense pulsed light and skin care products with anti-inflammatory properties to improve inflammatory erythema in rosacea

A retrospective study comparing intense pulsed light and skin care products with anti-inflammatory properties to improve inflammatory erythema in rosacea

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400087665
Enrollment
Unknown
Registered
2024-08-01
Start date
2023-06-10
Completion date
Unknown
Last updated
2024-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rosacea

Interventions

Topical serum group:None
Intense pulsed light (IPL) group:None

Sponsors

Xiangya Hospital Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1) Females or males aged 18-55 years; 2) Patients diagnosed with rosacea according to the 2017 edition of the International Diagnostic Criteria for Rosacea; and patients with rosacea predominantly of the erythematous capillary dilatation type according to the 2002 International Committee of Rosacea Specialists typology; 3) Patients who have received Intense Pulsed Light (IPL) treatment or topical moisturizing agents in our clinic; 4) Subjects who have undergone retrospective collection of clinical data and are available to provide portraits; 5) Understanding and willingness to participate in this clinical study and voluntarily signing the informed consent form (all subjects were included).

Exclusion criteria

Exclusion criteria: 1) Presence of rosacea-associated pustules; 2) Lack of data related to the physical signs of rosacea (images or self-reported symptoms); 3) The presence of a serious systemic disease that may affect the results of the test; 4) Pregnant or breastfeeding women; 5) Have other facial skin disorders (e.g., psoriasis, eczema, infections); 6) Unable/unwilling to follow up.

Design outcomes

Primary

MeasureTime frame
Clinician's Erythema Assessment (CEA);

Secondary

MeasureTime frame
Physician Visual Assessment Score;Pore;sebum;skin tone;Hydration;Elasticity;Melanin;Patient attitudes and choices about treatment;

Countries

China

Contacts

Public ContactDan Jian

Xiangya hospital, Central south university

949848638@qq.com+86 173 7589 5813

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026